Tapewire

Nasdaq · USD

NMRA

Neumora Therapeutics, Inc.

Export transactions ↓
Tapewire entity
6115
SEC CIK
0001885522
Parsed reports
118

Last 12 months

Inside the activity.

0 purchase rows · 16 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202500
Jan 202600
Feb 202604
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 2026011
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 13, 2025 Filed Feb 18, 2025 21:30 UTC GrantStock Option (Right to Buy) · Derivative 41,250 Not disclosed Strike: $1.69 Not disclosed
Disclosure

SEC source: 0000950170-25-022325 · ownership.xml · derivative · entry 9

Milligan Michael Lee · CIK 0001993953 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,250

Underlying: Common Stock · 41,250 shares

Expires 2034-02-14

F7 · derivative.exercise_price: Effective February 13, 2025, subject to and contingent on the approval by the Issuer's stockholders, the Board approved an option repricing with an exercise price of $1.69 per share (the "Repricing") of the outstanding stock options held by members of the Board, certain employees and other service providers, provided that if the requisite approval of the Issuer's stockholders is not obtained, the Repricing will be void and the terms of each repriced option shall continue to be subject to its original terms and conditions, including, without limitation, the per share exercise price. The Repricing is subject to the Reporting Person remaining in service to the Issuer through August 13, 2026.

F3 · price: On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 7, all other terms of the option remain unchanged.

F6 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from February 14, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 21:30 UTC GrantStock Option (Right to Buy) · Derivative 28,675 Not disclosed Strike: $1.69 Not disclosed
Disclosure

SEC source: 0000950170-25-022325 · ownership.xml · derivative · entry 8

Milligan Michael Lee · CIK 0001993953 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,675

Underlying: Common Stock · 28,675 shares

Expires 2033-06-23

F7 · derivative.exercise_price: Effective February 13, 2025, subject to and contingent on the approval by the Issuer's stockholders, the Board approved an option repricing with an exercise price of $1.69 per share (the "Repricing") of the outstanding stock options held by members of the Board, certain employees and other service providers, provided that if the requisite approval of the Issuer's stockholders is not obtained, the Repricing will be void and the terms of each repriced option shall continue to be subject to its original terms and conditions, including, without limitation, the per share exercise price. The Repricing is subject to the Reporting Person remaining in service to the Issuer through August 13, 2026.

F3 · price: On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 7, all other terms of the option remain unchanged.

F5 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from June 30, 2023 (the "Vesting Commencement Date'), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 21:30 UTC GrantStock Option (Right to Buy) · Derivative 38,234 Not disclosed Strike: $1.69 Not disclosed
Disclosure

SEC source: 0000950170-25-022325 · ownership.xml · derivative · entry 7

Milligan Michael Lee · CIK 0001993953 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,234

Underlying: Common Stock · 38,234 shares

Expires 2033-02-17

F7 · derivative.exercise_price: Effective February 13, 2025, subject to and contingent on the approval by the Issuer's stockholders, the Board approved an option repricing with an exercise price of $1.69 per share (the "Repricing") of the outstanding stock options held by members of the Board, certain employees and other service providers, provided that if the requisite approval of the Issuer's stockholders is not obtained, the Repricing will be void and the terms of each repriced option shall continue to be subject to its original terms and conditions, including, without limitation, the per share exercise price. The Repricing is subject to the Reporting Person remaining in service to the Issuer through August 13, 2026.

F3 · price: On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 7, all other terms of the option remain unchanged.

F4 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from February 1, 2023 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 21:30 UTC GrantStock Option (Right to Buy) · Derivative 85,391 Not disclosed Strike: $1.69 Not disclosed
Disclosure

SEC source: 0000950170-25-022325 · ownership.xml · derivative · entry 6

Milligan Michael Lee · CIK 0001993953 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 85,391

Underlying: Common Stock · 85,391 shares

Expires 2032-01-27

F7 · derivative.exercise_price: Effective February 13, 2025, subject to and contingent on the approval by the Issuer's stockholders, the Board approved an option repricing with an exercise price of $1.69 per share (the "Repricing") of the outstanding stock options held by members of the Board, certain employees and other service providers, provided that if the requisite approval of the Issuer's stockholders is not obtained, the Repricing will be void and the terms of each repriced option shall continue to be subject to its original terms and conditions, including, without limitation, the per share exercise price. The Repricing is subject to the Reporting Person remaining in service to the Issuer through August 13, 2026.

F3 · price: On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 7, all other terms of the option remain unchanged.

F2 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from December 20, 2021 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 21:30 UTC Disposition to issuerStock Option (Right to Buy) · Derivative 41,250 Not disclosed Strike: $18.07 Not disclosed
Disclosure

SEC source: 0000950170-25-022325 · ownership.xml · derivative · entry 5

Milligan Michael Lee · CIK 0001993953 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 41,250 shares

Expires 2034-02-14

F3 · price: On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 7, all other terms of the option remain unchanged.

F6 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from February 14, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 21:30 UTC Disposition to issuerStock Option (Right to Buy) · Derivative 28,675 Not disclosed Strike: $6.36 Not disclosed
Disclosure

SEC source: 0000950170-25-022325 · ownership.xml · derivative · entry 4

Milligan Michael Lee · CIK 0001993953 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 28,675 shares

Expires 2033-06-23

F3 · price: On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 7, all other terms of the option remain unchanged.

F5 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from June 30, 2023 (the "Vesting Commencement Date'), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 21:30 UTC Disposition to issuerStock Option (Right to Buy) · Derivative 38,234 Not disclosed Strike: $6.51 Not disclosed
Disclosure

SEC source: 0000950170-25-022325 · ownership.xml · derivative · entry 3

Milligan Michael Lee · CIK 0001993953 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 38,234 shares

Expires 2033-02-17

F3 · price: On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 7, all other terms of the option remain unchanged.

F4 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from February 1, 2023 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 21:30 UTC Disposition to issuerStock Option (Right to Buy) · Derivative 85,391 Not disclosed Strike: $4.63 Not disclosed
Disclosure

SEC source: 0000950170-25-022325 · ownership.xml · derivative · entry 2

Milligan Michael Lee · CIK 0001993953 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 85,391 shares

Expires 2032-01-27

F3 · price: On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 7, all other terms of the option remain unchanged.

F2 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from December 20, 2021 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 21:30 UTC GrantStock Option (Right to Buy) · Derivative 400,000 $0.00 Strike: $1.69 $0.00
Disclosure

SEC source: 0000950170-25-022325 · ownership.xml · derivative · entry 1

Milligan Michael Lee · CIK 0001993953 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 400,000

Underlying: Common Stock · 400,000 shares

Expires 2035-02-13

F1 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from February 13, 2025 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 21:30 UTC
Duncan JasonSee Remarks
GrantStock Option (Right to Buy) · Derivative 400,000 Not disclosed Strike: $1.69 Not disclosed
Disclosure

SEC source: 0000950170-25-022316 · ownership.xml · derivative · entry 3

Duncan Jason · CIK 0001741553 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 400,000

Underlying: Common Stock · 400,000 shares

Expires 2033-12-11

F4 · derivative.exercise_price: Effective February 13, 2025, subject to and contingent on the approval by the Issuer's stockholders, the Board approved an option repricing with an exercise price of $1.69 per share (the "Repricing") of the outstanding stock options held by members of the Board, certain employees and other service providers, provided that if the requisite approval of the Issuer's stockholders is not obtained, the Repricing will be void and the terms of each repriced option shall continue to be subject to its original terms and conditions, including, without limitation, the per share exercise price. The Repricing is subject to the Reporting Person remaining in service to the Issuer through August 13, 2026.

F3 · price: On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged.

F2 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from December 11, 2023 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 21:30 UTC
Duncan JasonSee Remarks
Disposition to issuerStock Option (Right to Buy) · Derivative 400,000 Not disclosed Strike: $12.97 Not disclosed
Disclosure

SEC source: 0000950170-25-022316 · ownership.xml · derivative · entry 2

Duncan Jason · CIK 0001741553 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 400,000 shares

Expires 2033-12-11

F3 · price: On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged.

F2 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from December 11, 2023 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 21:30 UTC
Duncan JasonSee Remarks
GrantStock Option (Right to Buy) · Derivative 500,000 $0.00 Strike: $1.69 $0.00
Disclosure

SEC source: 0000950170-25-022316 · ownership.xml · derivative · entry 1

Duncan Jason · CIK 0001741553 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires 2035-02-13

F1 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from February 13, 2025 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 21:30 UTC
Pinto JoshuaPresident
GrantStock Option (Right to Buy) · Derivative 170,000 Not disclosed Strike: $1.69 Not disclosed
Disclosure

SEC source: 0000950170-25-022319 · ownership.xml · derivative · entry 13

Pinto Joshua · CIK 0001992595 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 170,000

Underlying: Common Stock · 170,000 shares

Expires 2034-02-14

F9 · derivative.exercise_price: Effective February 13, 2025, subject to and contingent on the approval by the Issuer's stockholders, the Board approved an option repricing with an exercise price of $1.69 per share (the "Repricing") of the outstanding stock options held by members of the Board, certain employees and other service providers, provided that if the requisite approval of the Issuer's stockholders is not obtained, the Repricing will be void and the terms of each repriced option shall continue to be subject to its original terms and conditions, including, without limitation, the per share exercise price. The Repricing is subject to the Reporting Person remaining in service to the Issuer through August 13, 2026.

F3 · price: On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 9, all other terms of the option remain unchanged.

F8 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from February 14, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 21:30 UTC
Pinto JoshuaPresident
GrantStock Option (Right to Buy) · Derivative 127,448 Not disclosed Strike: $1.69 Not disclosed
Disclosure

SEC source: 0000950170-25-022319 · ownership.xml · derivative · entry 12

Pinto Joshua · CIK 0001992595 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 127,448

Underlying: Common Stock · 127,448 shares

Expires 2033-06-23

F9 · derivative.exercise_price: Effective February 13, 2025, subject to and contingent on the approval by the Issuer's stockholders, the Board approved an option repricing with an exercise price of $1.69 per share (the "Repricing") of the outstanding stock options held by members of the Board, certain employees and other service providers, provided that if the requisite approval of the Issuer's stockholders is not obtained, the Repricing will be void and the terms of each repriced option shall continue to be subject to its original terms and conditions, including, without limitation, the per share exercise price. The Repricing is subject to the Reporting Person remaining in service to the Issuer through August 13, 2026.

F3 · price: On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 9, all other terms of the option remain unchanged.

F7 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from June 30, 2023 (the "Vesting Commencement Date'), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 21:30 UTC
Pinto JoshuaPresident
GrantStock Option (Right to Buy) · Derivative 720,084 Not disclosed Strike: $1.69 Not disclosed
Disclosure

SEC source: 0000950170-25-022319 · ownership.xml · derivative · entry 11

Pinto Joshua · CIK 0001992595 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 720,084

Underlying: Common Stock · 720,084 shares

Expires 2032-01-27

F9 · derivative.exercise_price: Effective February 13, 2025, subject to and contingent on the approval by the Issuer's stockholders, the Board approved an option repricing with an exercise price of $1.69 per share (the "Repricing") of the outstanding stock options held by members of the Board, certain employees and other service providers, provided that if the requisite approval of the Issuer's stockholders is not obtained, the Repricing will be void and the terms of each repriced option shall continue to be subject to its original terms and conditions, including, without limitation, the per share exercise price. The Repricing is subject to the Reporting Person remaining in service to the Issuer through August 13, 2026.

F3 · price: On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 9, all other terms of the option remain unchanged.

F6 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from February 1, 2022 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 21:30 UTC
Pinto JoshuaPresident
GrantStock Option (Right to Buy) · Derivative 223,034 Not disclosed Strike: $1.69 Not disclosed
Disclosure

SEC source: 0000950170-25-022319 · ownership.xml · derivative · entry 10

Pinto Joshua · CIK 0001992595 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 223,034

Underlying: Common Stock · 223,034 shares

Expires 2031-06-07

F9 · derivative.exercise_price: Effective February 13, 2025, subject to and contingent on the approval by the Issuer's stockholders, the Board approved an option repricing with an exercise price of $1.69 per share (the "Repricing") of the outstanding stock options held by members of the Board, certain employees and other service providers, provided that if the requisite approval of the Issuer's stockholders is not obtained, the Repricing will be void and the terms of each repriced option shall continue to be subject to its original terms and conditions, including, without limitation, the per share exercise price. The Repricing is subject to the Reporting Person remaining in service to the Issuer through August 13, 2026.

F3 · price: On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 9, all other terms of the option remain unchanged.

F5 · derivative.exercise_date: The performance-based stock option becomes exercisable in two tranches upon the achievement of specified stock price milestones. Each tranche shall vest in 24 equal monthly installments measured from the stock price achievement date.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 21:30 UTC
Pinto JoshuaPresident
GrantStock Option (Right to Buy) · Derivative 270,828 Not disclosed Strike: $1.69 Not disclosed
Disclosure

SEC source: 0000950170-25-022319 · ownership.xml · derivative · entry 9

Pinto Joshua · CIK 0001992595 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 270,828

Underlying: Common Stock · 270,828 shares

Expires 2031-06-07

F9 · derivative.exercise_price: Effective February 13, 2025, subject to and contingent on the approval by the Issuer's stockholders, the Board approved an option repricing with an exercise price of $1.69 per share (the "Repricing") of the outstanding stock options held by members of the Board, certain employees and other service providers, provided that if the requisite approval of the Issuer's stockholders is not obtained, the Repricing will be void and the terms of each repriced option shall continue to be subject to its original terms and conditions, including, without limitation, the per share exercise price. The Repricing is subject to the Reporting Person remaining in service to the Issuer through August 13, 2026.

F3 · price: On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 9, all other terms of the option remain unchanged.

F4 · derivative.exercise_date: The option is early exercisable. 1/36th of the shares subject to the option vest on each monthly anniversary measured from June 1, 2022 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested on the third anniversary of the Vesting Commencement Date.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 21:30 UTC
Pinto JoshuaPresident
GrantStock Option (Right to Buy) · Derivative 223,034 Not disclosed Strike: $1.69 Not disclosed
Disclosure

SEC source: 0000950170-25-022319 · ownership.xml · derivative · entry 8

Pinto Joshua · CIK 0001992595 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 223,034

Underlying: Common Stock · 223,034 shares

Expires 2031-06-07

F9 · derivative.exercise_price: Effective February 13, 2025, subject to and contingent on the approval by the Issuer's stockholders, the Board approved an option repricing with an exercise price of $1.69 per share (the "Repricing") of the outstanding stock options held by members of the Board, certain employees and other service providers, provided that if the requisite approval of the Issuer's stockholders is not obtained, the Repricing will be void and the terms of each repriced option shall continue to be subject to its original terms and conditions, including, without limitation, the per share exercise price. The Repricing is subject to the Reporting Person remaining in service to the Issuer through August 13, 2026.

F3 · price: On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 9, all other terms of the option remain unchanged.

F2 · derivative.exercise_date: 1/36th of the shares subject to the option vest on each monthly anniversary measured from June 30, 2023 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 21:30 UTC
Pinto JoshuaPresident
Disposition to issuerStock Option (Right to Buy) · Derivative 170,000 Not disclosed Strike: $18.07 Not disclosed
Disclosure

SEC source: 0000950170-25-022319 · ownership.xml · derivative · entry 7

Pinto Joshua · CIK 0001992595 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 170,000 shares

Expires 2034-02-14

F3 · price: On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 9, all other terms of the option remain unchanged.

F8 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from February 14, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 21:30 UTC
Pinto JoshuaPresident
Disposition to issuerStock Option (Right to Buy) · Derivative 127,448 Not disclosed Strike: $6.36 Not disclosed
Disclosure

SEC source: 0000950170-25-022319 · ownership.xml · derivative · entry 6

Pinto Joshua · CIK 0001992595 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 127,448 shares

Expires 2033-06-23

F3 · price: On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 9, all other terms of the option remain unchanged.

F7 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from June 30, 2023 (the "Vesting Commencement Date'), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 21:30 UTC
Pinto JoshuaPresident
Disposition to issuerStock Option (Right to Buy) · Derivative 720,084 Not disclosed Strike: $4.63 Not disclosed
Disclosure

SEC source: 0000950170-25-022319 · ownership.xml · derivative · entry 5

Pinto Joshua · CIK 0001992595 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 720,084 shares

Expires 2032-01-27

F3 · price: On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 9, all other terms of the option remain unchanged.

F6 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from February 1, 2022 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 21:30 UTC
Pinto JoshuaPresident
Disposition to issuerStock Option (Right to Buy) · Derivative 223,034 Not disclosed Strike: $2.51 Not disclosed
Disclosure

SEC source: 0000950170-25-022319 · ownership.xml · derivative · entry 4

Pinto Joshua · CIK 0001992595 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 223,034 shares

Expires 2031-06-07

F3 · price: On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 9, all other terms of the option remain unchanged.

F5 · derivative.exercise_date: The performance-based stock option becomes exercisable in two tranches upon the achievement of specified stock price milestones. Each tranche shall vest in 24 equal monthly installments measured from the stock price achievement date.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 21:30 UTC
Pinto JoshuaPresident
Disposition to issuerStock Option (Right to Buy) · Derivative 270,828 Not disclosed Strike: $2.51 Not disclosed
Disclosure

SEC source: 0000950170-25-022319 · ownership.xml · derivative · entry 3

Pinto Joshua · CIK 0001992595 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 270,828 shares

Expires 2031-06-07

F3 · price: On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 9, all other terms of the option remain unchanged.

F4 · derivative.exercise_date: The option is early exercisable. 1/36th of the shares subject to the option vest on each monthly anniversary measured from June 1, 2022 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested on the third anniversary of the Vesting Commencement Date.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 21:30 UTC
Pinto JoshuaPresident
Disposition to issuerStock Option (Right to Buy) · Derivative 223,034 Not disclosed Strike: $2.51 Not disclosed
Disclosure

SEC source: 0000950170-25-022319 · ownership.xml · derivative · entry 2

Pinto Joshua · CIK 0001992595 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 223,034 shares

Expires 2031-06-07

F3 · price: On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 9, all other terms of the option remain unchanged.

F2 · derivative.exercise_date: 1/36th of the shares subject to the option vest on each monthly anniversary measured from June 30, 2023 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 21:30 UTC
Pinto JoshuaPresident
GrantStock Option (Right to Buy) · Derivative 3,000,000 $0.00 Strike: $1.69 $0.00
Disclosure

SEC source: 0000950170-25-022319 · ownership.xml · derivative · entry 1

Pinto Joshua · CIK 0001992595 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,000,000

Underlying: Common Stock · 3,000,000 shares

Expires 2035-02-13

F1 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from February 13, 2025 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 21:30 UTC
Halawa AlaaDirector
GrantStock Option (Right to Buy) · Derivative 28,571 Not disclosed Strike: $1.69 Not disclosed
Disclosure

SEC source: 0000950170-25-022318 · ownership.xml · derivative · entry 4

Halawa Alaa · CIK 0001992622 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,571

Underlying: Common Stock · 28,571 shares

Expires 2034-06-13

F4 · derivative.exercise_price: Effective February 13, 2025, subject to and contingent on the approval by the Issuer's stockholders, the Board approved an option repricing with an exercise price of $1.69 per share (the "Repricing") of the outstanding stock options held by members of the Board, certain employees and other service providers, provided that if the requisite approval of the Issuer's stockholders is not obtained, the Repricing will be void and the terms of each repriced option shall continue to be subject to its original terms and conditions, including, without limitation, the per share exercise price. The Repricing is subject to the Reporting Person remaining in service to the Issuer through August 13, 2026.

F2 · price: On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged.

F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of (i) one year anniversary of June 13, 2024 or (ii) immediately prior to the next Annual Meeting following June 13, 2024.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 21:30 UTC
Halawa AlaaDirector
GrantStock Option (Right to Buy) · Derivative 46,455 Not disclosed Strike: $1.69 Not disclosed
Disclosure

SEC source: 0000950170-25-022318 · ownership.xml · derivative · entry 3

Halawa Alaa · CIK 0001992622 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,455

Underlying: Common Stock · 46,455 shares

Expires 2033-09-14

F4 · derivative.exercise_price: Effective February 13, 2025, subject to and contingent on the approval by the Issuer's stockholders, the Board approved an option repricing with an exercise price of $1.69 per share (the "Repricing") of the outstanding stock options held by members of the Board, certain employees and other service providers, provided that if the requisite approval of the Issuer's stockholders is not obtained, the Repricing will be void and the terms of each repriced option shall continue to be subject to its original terms and conditions, including, without limitation, the per share exercise price. The Repricing is subject to the Reporting Person remaining in service to the Issuer through August 13, 2026.

F2 · price: On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged.

F1 · derivative.exercise_date: 1/36th of the shares subject to the option vest on each monthly anniversary measured from September 14, 2023 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 21:30 UTC
Halawa AlaaDirector
Disposition to issuerStock Option (Right to Buy) · Derivative 28,571 Not disclosed Strike: $9.95 Not disclosed
Disclosure

SEC source: 0000950170-25-022318 · ownership.xml · derivative · entry 2

Halawa Alaa · CIK 0001992622 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 28,571 shares

Expires 2034-06-13

F2 · price: On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged.

F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of (i) one year anniversary of June 13, 2024 or (ii) immediately prior to the next Annual Meeting following June 13, 2024.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 21:30 UTC
Halawa AlaaDirector
Disposition to issuerStock Option (Right to Buy) · Derivative 46,455 Not disclosed Strike: $17.00 Not disclosed
Disclosure

SEC source: 0000950170-25-022318 · ownership.xml · derivative · entry 1

Halawa Alaa · CIK 0001992622 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 46,455 shares

Expires 2023-09-14

F2 · price: On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged.

F1 · derivative.exercise_date: 1/36th of the shares subject to the option vest on each monthly anniversary measured from September 14, 2023 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date.

Read SEC document
December 27, 2024 Filed Dec 27, 2024 22:01 UTC
BERNS PAUL LDirector
GiftCommon Stock 133,097 $0.00 $0.00
Disclosure

SEC source: 0001610717-24-000555 · form4.xml · nonDerivative · entry 5

BERNS PAUL L · CIK 0001202769 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,418,875

F1 · kind: On December 27, 2024, the Reporting Person transferred, for no consideration, 133,097 shares of Common Stock to each of LULU TRUST OF 2024 FBO AB, LULU TRUST OF 2024 FBO OB, and LULU TRUST OF 2024 FBO HB, of which members of the Reporting Person's immediate family are the sole beneficiaries.

Read SEC document
December 27, 2024 Filed Dec 27, 2024 22:01 UTC
BERNS PAUL LDirector
GiftCommon Stock 133,097 $0.00 $0.00
Disclosure

SEC source: 0001610717-24-000555 · form4.xml · nonDerivative · entry 3

BERNS PAUL L · CIK 0001202769 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,551,972

F1 · kind: On December 27, 2024, the Reporting Person transferred, for no consideration, 133,097 shares of Common Stock to each of LULU TRUST OF 2024 FBO AB, LULU TRUST OF 2024 FBO OB, and LULU TRUST OF 2024 FBO HB, of which members of the Reporting Person's immediate family are the sole beneficiaries.

Read SEC document
December 27, 2024 Filed Dec 27, 2024 22:01 UTC
BERNS PAUL LDirector
GiftCommon Stock 133,097 $0.00 $0.00
Disclosure

SEC source: 0001610717-24-000555 · form4.xml · nonDerivative · entry 1

BERNS PAUL L · CIK 0001202769 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,685,069

F1 · kind: On December 27, 2024, the Reporting Person transferred, for no consideration, 133,097 shares of Common Stock to each of LULU TRUST OF 2024 FBO AB, LULU TRUST OF 2024 FBO OB, and LULU TRUST OF 2024 FBO HB, of which members of the Reporting Person's immediate family are the sole beneficiaries.

Read SEC document
October 18, 2024 Filed Oct 18, 2024 22:25 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 7,844 $0.00 Strike: $2.52 $0.00
Disclosure

SEC source: 0001610717-24-000511 · form4.xml · derivative · entry 12

Fust Matthew K · CIK 0001397266 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 85,586

Underlying: Common Stock · 7,844 shares

Expires 2031-04-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable.

Read SEC document
October 18, 2024 Filed Oct 18, 2024 22:25 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 6,205 $0.00 Strike: $8.79 $0.00
Disclosure

SEC source: 0001610717-24-000511 · form4.xml · derivative · entry 11

Fust Matthew K · CIK 0001397266 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,205 shares

Expires 2030-09-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable.

Read SEC document
October 18, 2024 Filed Oct 18, 2024 22:25 UTC SaleCommon Stock 14,049 $17.03 $239,319.10
Disclosure

SEC source: 0001610717-24-000511 · form4.xml · nonDerivative · entry 7

Fust Matthew K · CIK 0001397266 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,100

F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on May 10, 2024.

F3 · price: This transaction was executed in multiple trades in prices ranging from $17.00 to $17.15, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
October 18, 2024 Filed Oct 18, 2024 22:25 UTC Exercise / conversionCommon Stock 7,844 $2.52 $19,766.88
Disclosure

SEC source: 0001610717-24-000511 · form4.xml · nonDerivative · entry 6

Fust Matthew K · CIK 0001397266 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 34,149

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 18, 2024 Filed Oct 18, 2024 22:25 UTC Exercise / conversionCommon Stock 6,205 $8.79 $54,541.95
Disclosure

SEC source: 0001610717-24-000511 · form4.xml · nonDerivative · entry 5

Fust Matthew K · CIK 0001397266 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 26,305

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 17, 2024 Filed Oct 18, 2024 22:25 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 2,156 $0.00 Strike: $2.52 $0.00
Disclosure

SEC source: 0001610717-24-000511 · form4.xml · derivative · entry 10

Fust Matthew K · CIK 0001397266 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 93,430

Underlying: Common Stock · 2,156 shares

Expires 2031-04-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable.

Read SEC document
October 17, 2024 Filed Oct 18, 2024 22:25 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 1,800 $0.00 Strike: $8.79 $0.00
Disclosure

SEC source: 0001610717-24-000511 · form4.xml · derivative · entry 9

Fust Matthew K · CIK 0001397266 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,205

Underlying: Common Stock · 1,800 shares

Expires 2030-09-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable.

Read SEC document
October 17, 2024 Filed Oct 18, 2024 22:25 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 3,783 $0.00 Strike: $8.32 $0.00
Disclosure

SEC source: 0001610717-24-000511 · form4.xml · derivative · entry 8

Fust Matthew K · CIK 0001397266 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,783 shares

Expires 2030-09-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable.

Read SEC document
October 17, 2024 Filed Oct 18, 2024 22:25 UTC SaleCommon Stock 7,739 $17.01 $131,642.71
Disclosure

SEC source: 0001610717-24-000511 · form4.xml · nonDerivative · entry 4

Fust Matthew K · CIK 0001397266 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,100

F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on May 10, 2024.

F2 · price: This transaction was executed in multiple trades in prices ranging from $17.00 to $17.045, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
October 17, 2024 Filed Oct 18, 2024 22:25 UTC Exercise / conversionCommon Stock 2,156 $2.52 $5,433.12
Disclosure

SEC source: 0001610717-24-000511 · form4.xml · nonDerivative · entry 3

Fust Matthew K · CIK 0001397266 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 27,839

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 17, 2024 Filed Oct 18, 2024 22:25 UTC Exercise / conversionCommon Stock 1,800 $8.79 $15,822.00
Disclosure

SEC source: 0001610717-24-000511 · form4.xml · nonDerivative · entry 2

Fust Matthew K · CIK 0001397266 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 25,683

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 17, 2024 Filed Oct 18, 2024 22:25 UTC Exercise / conversionCommon Stock 3,783 $8.32 $31,474.56
Disclosure

SEC source: 0001610717-24-000511 · form4.xml · nonDerivative · entry 1

Fust Matthew K · CIK 0001397266 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 23,883

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 10, 2024 Filed Oct 11, 2024 20:10 UTC
Lenz Robert A.Head of R&D
SaleCommon Stock 8,260 $15.09 $124,602.93
Disclosure

SEC source: 0001610717-24-000505 · form4.xml · nonDerivative · entry 2

Lenz Robert A. · CIK 0001992908 · Head of R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 314,706

F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on June 12, 2024.

F3 · price: This transaction was executed in multiple trades in prices ranging from $15.00 to 15.2435, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
October 09, 2024 Filed Oct 11, 2024 20:10 UTC
Lenz Robert A.Head of R&D
SaleCommon Stock 5,563 $15.01 $83,507.31
Disclosure

SEC source: 0001610717-24-000505 · form4.xml · nonDerivative · entry 1

Lenz Robert A. · CIK 0001992908 · Head of R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 322,966

F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on June 12, 2024.

F2 · price: This transaction was executed in multiple trades in prices ranging from $15.00 to $15.065, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
September 18, 2024 Filed Sep 19, 2024 20:35 UTC
Lenz Robert A.Head of R&D
SaleCommon Stock 10,676 $12.09 $129,090.99
Disclosure

SEC source: 0001610717-24-000490 · form4.xml · nonDerivative · entry 2

Lenz Robert A. · CIK 0001992908 · Head of R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 328,529

F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on June 12, 2024.

F3 · price: This transaction was executed in multiple trades in prices ranging from $12.00 to $12.18, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
September 17, 2024 Filed Sep 19, 2024 20:35 UTC
Lenz Robert A.Head of R&D
SaleCommon Stock 30,788 $11.81 $363,735.59
Disclosure

SEC source: 0001610717-24-000490 · form4.xml · nonDerivative · entry 1

Lenz Robert A. · CIK 0001992908 · Head of R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 339,205

F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on June 12, 2024.

F2 · price: This transaction was executed in multiple trades in prices ranging from $11.5985 to $12.08, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
September 12, 2024 Filed Sep 13, 2024 21:22 UTC
Aurora Daljit SinghChief Strategy Officer
GiftStock Option (Right to Buy) · Derivative 29,737 $0.00 Strike: $6.36 $0.00
Disclosure

SEC source: 0001610717-24-000475 · form4.xml · derivative · entry 8

Aurora Daljit Singh · CIK 0001793971 · Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 29,737

Underlying: Common Stock · 29,737 shares

Expires 2033-06-22

F2 · kind: Represents fully vested stock options transferred pursuant to an option transfer agreement dated September 12, 2024 between the Reporting Person and Aurora Family Trust, of which members of the Reporting Person's immediate family are the sole beneficiaries.

F2 · derivative.exercise_date: Represents fully vested stock options transferred pursuant to an option transfer agreement dated September 12, 2024 between the Reporting Person and Aurora Family Trust, of which members of the Reporting Person's immediate family are the sole beneficiaries.

F1 · ownership.nature: Shares held by Aurora Family Trust.

Read SEC document
September 12, 2024 Filed Sep 13, 2024 21:22 UTC
Aurora Daljit SinghChief Strategy Officer
GiftStock Option (Right to Buy) · Derivative 29,737 $0.00 Strike: $6.36 $0.00
Disclosure

SEC source: 0001610717-24-000475 · form4.xml · derivative · entry 7

Aurora Daljit Singh · CIK 0001793971 · Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,221

Underlying: Common Stock · 29,737 shares

Expires 2033-06-22

F2 · kind: Represents fully vested stock options transferred pursuant to an option transfer agreement dated September 12, 2024 between the Reporting Person and Aurora Family Trust, of which members of the Reporting Person's immediate family are the sole beneficiaries.

F2 · derivative.exercise_date: Represents fully vested stock options transferred pursuant to an option transfer agreement dated September 12, 2024 between the Reporting Person and Aurora Family Trust, of which members of the Reporting Person's immediate family are the sole beneficiaries.

F5 · balance_after: 25% of the shares subject to the option vest on the first anniversary measured from June 30, 2023 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.